All of the people in these studies ... After 4 months in the study, the people who used Skyrizi were more likely to have clear or almost-clear skin (a score of 0 or 1 on the sPGA).

In the first phase of the studies (Period 1), patients were randomized to SKYRIZI or placebo through week 24. At week 24, the open-label extension (Period 2) began, and all patients were treated ...

had achieved clear or almost clear skin, with 19.6% having no skin lesions at all week 16, rising to 26.2% after a year. Skyrizi – partnered with Boehringer Ingelheim – is already enjoying ...

BTIG analyst Julian Harrison expects icotrokinra to "complement rather than disrupt" market leaders, including J&J's Tremfya and AbbVie's (ABBV.N), opens new tab Skyrizi. Icotrokinra helped 66% of ...

and fungal skin infections. These are not all the possible side effects of SKYRIZI. Call your doctor for medical advice about side effects. Use SKYRIZI exactly as your healthcare provider tells ...

The 60-second Skyrizi spot, which launched in mid ... The theme, and the name of the spot, “all in on clear skin,” chimes throughout. The ad uses the same jingle as AbbVie has used for the ...

and fungal skin infections. These are not all the possible side effects of SKYRIZI. Call your doctor for medical advice about side effects. Use SKYRIZI exactly as your healthcare provider tells ...

fungal skin infections, headache, and injection site reactions. These are not all the possible side effects of SKYRIZI. Call your doctor for medical advice about side effects. Use SKYRIZI exactly ...

including J&J's Tremfya and AbbVie's Skyrizi. Icotrokinra helped 66% of patients with scalp psoriasis and 77% of those with genital psoriasis achieve significantly clear skin compared to 11% and 21% ...